BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA® (Dinutuximab Beta) for Patients With High-Risk Neuroblastoma
CAMBRIDGE, Mass. & BEIJING & HEMEL HEMPSTEAD, England–(BUSINESS WIRE)– BeiGene, Ltd. (NASDAQ:BGNE; HKEX:06160) and EUSA Pharma (UK), Ltd. today announced that the China National Medical...